Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...

Amber Glenn earned zero points in a category for an “invalid element” after failing to do a triple loop. | Geoff Burke-Imagn Images Amber Glenn lost major points in her short program routine on ...

Editor's note: Alysa Liu won Olympic gold in women's figure skating. MILAN — The night started with promise and hope for the U.S. women's figure skating team. The trio of "Blade Angels" — close ...

Joe Grantham is a contributor from the UK with a degree in Classical Studies. His love for gaming is only rivaled by a deep passion for medieval history, which often seeps into his articles. With over ...

The shingles vaccine not only offers protection against the painful viral infection, a new study suggests that the two-dose shot also may slow the progression of dementia. Shingles, caused by the ...

ROME — The US Navy is cancelling its Constellation frigate program following months of cost overruns and delays but plans to keep two vessels that are already being built in Wisconsin. “We’re ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, drugmaker Novo Nordisk ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression Endocrinologist Daniel ...

The University Senate voted at an Oct. 24 plenary to approve the creation of a Master of Science in artificial intelligence, a new master’s degree in the School of Engineering and Applied Science. The ...

When engineers build AI language models like GPT-5 from training data, at least two major processing features emerge: memorization (reciting exact text they’ve seen before, like famous quotes or ...

In the final analysis, iptacopan was found to statistically significantly slow IgAN progression compared with placebo. Final results were announced from the phase 3 APPLAUSE-IgAN trial evaluating ...